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Mid-Ventricular Hypertrophic Obstructive 
Cardiomyopathy
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ABSTRACT
Mid-ventricular hypertrophic obstructive cardiomyopathy is a 
rare variant form (1%) of hypertrophic obstructive cardiomy-
opathy. In this case, we report a patient referred for elective 
cardiac catheterization due to angina and dyspnea on moder-
ate exertion, with no significant coronary obstruction, and left 
ventriculography indicating the presence of mid-ventricular 
hypertrophic obstructive cardiomyopathy with an intraventricular 
pressure gradient of 130  mmHg.
DESCRIPTORS: Cardiomyopathy, hypertrophic. Cardiac cathe-
terization.Ventricular outflow obstruction, left.
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RESUMO
Cardiomiopatia Hipertrófica  
Obstrutiva Médio-Ventricular
A cardiomiopatia hipertrófica obstrutiva médio-ventricular é uma 
variante rara (1%) da miocardiopatia hipertrófica obstrutiva. 
Neste relato de caso, apresentamos uma paciente encaminhada 
para realização de cateterismo cardíaco eletivo por angina e 
dispneia aos moderados esforços, sem obstrução coronariana 
significativa e com ventriculografia esquerda, demostrando 
cardiomiopatia hipertrófica obstrutiva médio-ventricular com 
um gradiente pressórico intraventricular de 130  mmHg.
DESCRITORES: Miocardiopatia hipertrófica. Cateterismo car-
díaco. Obstrução do fluxo ventricular esquerdo.
Case Report
M id-ventricular hypertrophic obstructive cardio-myopathy, first described by Falicov et al.1 in 1976, is a rare type (1%) of hypertrophic 
obstructive cardiomyopathy.2 In this variant, there is a 
significant mid-ventricular hypertrophy associated with 
a mid-ventricular stenosis, which confers the aspect of 
a dumbbell to the left ventricle,3 with generation of a 
pressure gradient between the apical and basal cham-
bers, as well as an absence of obstruction of outflow.2
CASE REPORT
A female patient, 80 years, was referred for elec-
tive cardiac catheterization due to angina and dyspnea 
on moderate exertion. Physical examination revealed 
mid-systolic murmur without other significant findings. 
An electrocardiogram showed criteria for left ventricular 
hypertrophy and secondary changes in ventricular 
repolarization (Figure  1). The coronary angiography 
showed no significant coronary stenoses; however, 
a left ventriculography in the right anterior oblique 
projection (30°) revealed mid-ventricular hypertrophic 
obstructive cardiomyopathy (Figure 2); after analysis of 
intracavitary pressures, a gradient of 130 mmHg was 
calculated (Figure 3).
DISCUSSION
Midventricular hypertrophic obstructive cardio-
myopathy is a phenotype distinct of hypertrophic 
obstructive cardiomyopathy, associated with an 
unfavorable prognosis. Efthimiadis et al.,4 in a study 
comparing clinical characteristics and natural history 
of patients with hypertrophic cardiomyopathy, with 
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Apical aneurysms were observed in approximately 
25% of patients with mid-ventricular obstructive 
hypertrophic cardiomyopathy, and were almost 
unique to this group. Their presence served as a 
marker of an even worse clinical course.
and without mid-ventricular obstruction, observed 
that its presence is a strong and independent pre-
dictor of sudden death, as well as a determinant 
of progression to end-stage hypertrophic obstructive 
cardiomyopathy and to heart failure-related death. 
Figure 1 – Electrocardiogram with voltage criteria for left ventricular hypertrophy, secondary changes in ventricular repolarization, and deep inver-
sion of T waves.
Figure 2 – Left ventriculography showing severe mid-ventricular hypertrophy, with almost complete mid-ventricular obstruction and apical dilation 
during diastole (A) and systole (B); these findings are best observed in Figure 2C.
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Apical dilation may occur in cases of severe nar-
rowing and of progression to a “burned out apex”, 
with apical aneurysm formation in approximately 
10% of patients.3 The pathogenesis of myocardial 
necrosis remains unknown. It has been suggested that 
the apical aneurysm may be secondary to after-load 
and to an increase of apical pressure, as a result of 
a mid-ventricular obstruction seen in the degenera-
tive process of hypertrophic cardiomyopathy. Other 
possible causes of aneurysm formation are small 
vessel disease with decreased coronary flow reserve, 
coronary stenosis due to an increased wall stress in 
the hypertrophied myocardial segment, decreased 
coronary perfusion pressure due to the mid-ventricular 
obstruction, coronary spasm, and decreased capillary/
myocardial fiber ratio.5
If left untreated, the midventricular obstructive hy-
pertrophic cardiomyopathy can cause fatal ventricular 
arrhythmias and sudden death. Beta-blockers are the 
first therapeutic choice for hypertrophic obstructive 
cardiomyopathy, but the treatment of mid-ventricular 
obstructive hypertrophic cardiomyopathy remains unclear. 
Dual-chamber pacemaker6 and percutaneous myocardial 
ablation7,8 have been proposed as non-surgical treat-
ments, but the long-term benefits and safety of these 
therapeutic options require further study.5 The surgical 
treatment of midventricular hypertrophic obstructive 
cardiomyopathy is poorly described in the literature, 
mostly in the form of case reports.9 Kunkala et al.,9 
in a recent study involving 56 patients, described the 
results of a transapical approach, noting that this op-
tion allows an excellent approach for myectomy, as 
well as for the relief of the intraventricular gradient 
and associated symptoms without any complications 
related to the apical incision were observed with a 
five-year survival similar to that expected in the general 
population (95% vs. 97%).
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
FUNDING SOURCE
None.
REFERENCES
 1. Falicov RE, Renekov L, Bharaki S, Lev M. Mid-ventricular 
obstruction: a variant of obstructive cardiomyopathy. Am J 
Cardiol. 1976;37(3):432-7.
 2. Song H, Zhao C, Jinfa J, Yang L, Chen Y. Mid-ventricular hy-
pertrophic obstructive cardiomyopathy (MVHOCM) complicated 
with coronary artery disease: a case report. J Geriatr Cardiol. 
2008;5(3):190-2.
 3. Noureldin RA, Liu S, Nacif MS, Judge DP, Halushka MK, 
Abraham TP, et al. The diagnosis of hypertrophic cardiomy-
opathy by cardiovascular magnetic resonance. J Cardiovasc 
Magn Reson. 2012;14:17.
 4. Efthimiadis GK, Pagourelias ED, Parcharidou D, Gossios T, 
Kamperidis V, Theofilogiannakos EK, et al. Clinical charac-
teristics and natural history of hypertrophic cardiomyopathy 
with midventricular obstruction. Circ J. 2013;77(9):2366-74.
 5. Sato Y, Matsumoto N, Matsuo S, Yoda S, Kunimoto S, Saito 
S. Mid-ventricular hypertrophic obstructive cardiomyopathy 
presenting with acute myocardial infarction. Tex Heart Inst J. 
2007;34(4):475-8.
 6. Watanabe H, Kibira S, Saito T, Shimizu H, Abe T, Nakajima 
I, et al. Beneficial effect of dual-chamber pacing for a left 
midventricular obstruction with apical aneurysm. Circ J 
2002;66(10):981-4.
 7. Tengiz I, Ercan E, Turk UO. Percutaneous myocardial ablation 
for left mid-ventricular obstructive hypertrophic cardiomyopathy. 
Int J Cardiovasc Imaging. 2006;22(1):13-8.
 8. Seggewiss H, Faber L. Percutaneous septal ablation for hyper-
trophic cardiomyopathy and mid-ventricular obstruction. Eur 
J Echocardiogr. 2000;1(4):277-80.
 9. Kunkala MR, Schaff HV, Nishimura RA, Abel MD, Sorajja 
P, Dearani JA, et al. Transapical approach to myectomy for 
midventricular obstruction in hypertrophic cardiomyopathy. 
Ann Thorac Surg. 2013;96(2):564-70.
Figure 3 – Left ventricular pressures (center) in the apical (left) and basal (right) chambers, with pressure gradient of 130 mmHg.
